Previously we found that catalytically active PLK1 drives EMT in non-small cell lung cancer (NSCLC), upregulating extracellular matrix factors including TSG6, laminin γ2, and CD44. This evidence concerns the gene TNFAIP6 and non-small cell lung carcinoma.